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Research
Although water disinfection is essential for 
reducing the risk of pathogens in the public 
water supply, potentially harmful disinfection 
by-products (DBPs) such as trihalomethanes 
(THMs) can be formed by the reaction of 
chlorine and other disinfectants with natu-
rally occurring organic matter and inorganic 
chemi cals in the water. The presence of THMs 
in the domestic water supply results in wide-
spread exposure from activities such as water 
consumption, bathing, showering, and swim-
ming (Ashley et al. 2005; Backer et al. 2000; 
Cammann and Hubner 1995). Exposure to 
DBPs has been associated with an increased 
risk of bladder cancer (Cantor et al. 1987, 
2010; McGeehin et al. 1993; Villanueva 
et al. 2007). Although the evidence is not as 
strong, a recent meta-analysis on 13 differ-
ent studies suggested a small increased risk 
of colon (relative risk (RR), 1.27; 95% con-
fidence interval (CI): 1.08, 1.50) and rectal 
(RR, 1.30; 95% CI: 1.06, 1.59) cancer was 
associated with DBP exposures through drink-
ing water (Rahman et al. 2010). DBP exposure 
has also been associated with fetal growth but 
not with preterm delivery, as noted in a recent 
meta-analysis by Grellier et al. (2010). Most 
of the previous studies have shown a small 
but consistent increased risk of small for ges-
tational age/intrauterine growth retardation 
with increasing THM exposures (Bove et al. 
1995; Dodds et al. 1999; Hoffman et al. 2008; 
Porter et al. 2005; Wright et al. 2004; Yang 
et al. 2007), and three of four studies suggested 
an increased risk of stillbirth (Dodds et al. 
1999, 2004; King et al. 2000; Toledano et al. 
2005). There is also suggestive evidence of an 
association between DBP exposure with some 
cardiac defects (Hwang et al. 2008), but the 
evidence is not as strong for other outcomes 
such as miscarriages (Savitz et al. 2006; Waller 
et al. 2001). One of the limitations of previous 
epidemiological studies is uncertainty in the 
exposure measures used to characterize DBP 
mixtures of interest during the relevant critical 
periods of exposure.
THMs are usually the most abundant class 
of DBPs found in chlorinated drinking water 
in the United States (Krasner et al. 2006). 
THM concentrations correlate with levels of 
some other types of halogenated DBPs, allow-
ing THMs to be used as surrogate markers of 
DBPs (Obolensky and Singer 2005). However, 
the distribution among the four different THM 
species [chloroform (TCM), bromodichloro-
methane (BDCM), dibromo chloromethane 
(DBCM), and bromoform (TBM)] can vary 
appreciably, depending on the concentration 
of bromide in the water at the time chlorine is 
added for disinfection (Obolensky and Singer 
2005). Exposure assessment for THMs is 
complicated by this variation in the specia-
tion of the four THMs, multiple routes of 
exposure (i.e., ingestion, inhalation, dermal 
absorption), intra- and interindividual vari-
ability in behavior, and interindividual physio-
logical differences in absorption, distribution, 
metabolism, and excretion of the four THMs 
(Backer et al. 2000, 2008; Leavens et al. 2007). 
Blood and expired air biomarkers of THM 
exposure can be used to estimate internal 
dose (Gordon et al. 2006; LaKind et al. 2010; 
Weisel and Jo 1996), but these measures are 
strongly influenced by very recent exposures. 
For example, Lynberg et al. (2001) reported 
significant increases in blood THM levels after 
showering, while Nuckols et al. (2005) found 
that the greatest influence on blood THM 
concentrations was due to showering, bathing, 
and washing dishes by hand. Morning blood 
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Background: Epidemiological studies have used various measures to characterize trihalomethane 
(THM) exposures, but the relationship of these indicators to exposure biomarkers remains unclear.
oBjectives: We examined temporal and spatial variability in baseline blood THM concentrations 
and assessed the relationship between these concentrations and several exposure indicators (tap 
water concentration, water-use activities, multiroute exposure metrics). 
Methods: We measured water-use activity and THM concentrations in blood and residential tap 
water from 150 postpartum women from three U.S. locations.
results: Blood ΣTHM [sum of chloroform (TCM), bromodichloromethane (BDCM), dibromo-
chloromethane (DBCM), and bromoform (TBM)] concentrations varied by site and season. As 
expected based on variable tap water concentrations and toxicokinetic properties, the proportion of 
brominated species (BDCM, DBCM, and TBM) in blood varied by site (site 1, 24%; site 2, 29%; 
site 3, 57%) but varied less markedly than in tap water (site 1, 35%; site 2, 75%; site 3, 68%). The 
blood–water ΣTHM Spearman rank correlation coefficient was 0.36, with correlations higher for 
individual brominated species (BDCM, 0.62; DBCM, 0.53; TBM, 0.54) than for TCM (0.37). 
Noningestion water activities contributed more to the total exposure metric than did ingestion, but 
tap water THM concentrations were more predictive of blood THM levels than were metrics that 
incorporated water use.
conclusions: Spatial and temporal variability in THM concentrations was greater in water than in 
blood. We found consistent blood–water correlations across season and site for BDCM and DBCM, 
and multivariate regression results suggest that water THM concentrations may be an adequate 
surro gate for baseline blood levels.
key words: blood THM, blood–water correlations, brominated THMs, noningestion water activi-
ties, trihalomethanes. Environ Health Perspect 120:661–667 (2012). http://dx.doi.org/10.1289/
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samples collected before any major water-use 
activity can be expected to yield baseline THM 
concentrations, as experimental studies have 
shown that pre exposure breath levels of TCM 
were reached 4 hr after inhalation and dermal 
exposures during showering or bathing (Weisel 
and Jo 1996) and that baseline blood BDCM 
levels were attained approximately 4 hr after 
oral administration and 6–7 hr after dermal 
exposure (Leavens et al. 2007). Several factors 
may influence baseline blood THM measure-
ments: a) DBP concentrations based on forma-
tion dynamics in water distribution systems; 
b) exposures from sources other than water; 
c) ambient indoor air concentrations of each 
THM species (volatility decreases in the order: 
TCM > BDCM > DBCM > TBM); d) body 
burden and the relative timing of exposure; 
e) partitioning of each individual THM species 
between body fat and the blood, which is in 
turn affected by the lipophilicity of each THM 
(lipophilicity decreases in the order: TBM 
> DBCM > BDCM > TCM); f ) personal 
charac teristics and behavior (e.g., smoking, 
alcohol use, water-use patterns); and g) genetic 
and physiological differences that can affect 
THM metabolism (Blount et al. 2011).
Although some studies have identified 
important activities that contribute to peak 
blood THM levels, few studies have examined 
predictors of baseline exposures. Additionally, 
the relationship between blood THM levels 
and less direct measures of THM exposures 
has not been well characterized in an epide-
miological study. To further inform expo-
sure assessment efforts, we examined specific 
water-use activities measured from 24-hr diary 
data in relation to THMs in blood from 150 
postpartum women. The primary objectives 
of this study were to describe temporal and 
spatial variability in blood THM biomarkers 
and to assess the relationship between these 
blood THM biomarkers, water concentra-
tions, specific water-use activities, multiroute 
exposure metrics, and other covariates.
Materials and Methods
Selection of sites and participant recruitment. 
Right from the Start (RFTS) was a prospec-
tive cohort study of drinking water DBPs and 
pregnancy health conducted in three metro-
politan areas of the United States (Savitz et al. 
2005, 2006). We selected these locations 
to include a wide range of individual DBP 
species and summary measures such as the 
sum of TCM, BDCM, DBCM, and TBM 
(ΣTHM). Sites 1 and 3 had moderate levels 
of chlorinated and brominated DBPs, respec-
tively, and we chose them because they used 
chloramination rather than free chlorine for 
terminal disinfection. Chloramination results 
in minimal additional DBP formation within 
the distribution system; therefore, we would 
have expected all of the study participants 
within the same site to have similar tap water 
DBP concentrations for samples collected 
within the same week (Singer 1994). Site 2 
used free chlorine for the distribution system, 
but THM levels were so low that all consum-
ers were exposed to low THM levels from 
residential tap water.
To be eligible to participate in the RFTS 
study, women had to be ≥ 18 years of age, 
reside and remain in one of the three metro-
politan areas, use public drinking water, be 
able to speak and write English or Spanish, 
not have used assisted reproductive technol-
ogy, and be trying to become pregnant or 
pregnant at < 12 weeks of gestation, with 
the intent to carry the pregnancy to term 
(Promislow et al. 2004). Postpartum women 
who had participated in the RFTS study 
and were at least 30 days past delivery, not 
pregnant at the time of screening and enroll-
ment, still residing in the study areas, and 
using public drinking water were eligible 
for the study of blood THMs. The insti-
tutional review boards at the University of 
North Carolina–Chapel Hill, University of 
Tennessee, and University of Texas approved 
the study protocols, and participants gave 
informed consent. Among the total of 238 
women that were eligible and agreed to par-
ticipate, 153 (64%) provided blood and water 
samples [see Supplemental Material, Figure 1 
(http://dx.doi.org/10.1289/ehp.1104347)]. 
The participation rate was 76% for site 1 and 
57% for sites 1 and 2. To better assess sea-
sonal variation in DBP levels, we collected 
water and blood samples from a subset of 
women in the summer and winter from site 1 
(n = 29) and site 3 (n = 2). Blood and water 
samples were collected from January to March 
of 2004 (winter) for site 1, June to August of 
2004 (summer) for sites 1–3, and December 
2004 to January 2005 (winter) for site 3.
Blood and water sample collection and 
analysis. Trained personnel scheduled morn-
ing home visits to collect blood and tap water 
samples before the participants had any con-
tact with water. After signing a consent form, 
trained technicians (phlebotomists) collected 
a 10-mL blood sample from each participant 
via venipuncture into gray-top glass tubes 
(Vacutainer® Becton Dickinson, Franklin 
Lakes, NJ) that were specially treated before 
use to remove background THM contamina-
tion (Cardinali et al. 1995). We mixed the 
blood samples to dissolve the anticoagulant 
immediately after the blood draw. The techni-
cians collected a 12-mL water sample during 
the same home visit from a nonaerated, cold 
water tap. We kept all blood and water sam-
ples in coolers until they were shipped to the 
Centers for Disease Control and Prevention 
for analysis. We collected a total of 184 blood 
and water samples from 153 study participants. 
Seventy-four women provided blood samples 
in summer only, 48 in winter only, and 31 in 
both summer and winter. We excluded blood 
and water samples (n = 4) from two partici-
pants from the analysis because of laboratory 
data quality concerns, and we excluded the 
water and blood samples for another partici-
pant who was exposed through a key water-use 
activity within 1 hr of sampling. In addition, 
we did not examine four water samples because 
of unacceptable headspace volume and/or 
freezing of vials. A total of 179 blood sam-
ples and 175 water samples from 150 women 
were available for analysis [see Supplemental 
Material, Figure 1 (http://dx.doi.org/10.1289/
ehp.1104347)].
Isotope-dilution–based quantification 
of THM concentrations in tap water and 
blood samples was accomplished using solid-
 phase microextraction/gas chromatography 
(SPME/GC) with mass spectrometry (MS) 
(Cardinali et al. 2004) and high-resolution 
MS (Bonin et al. 2005), respectively. We 
added stable isotopically labeled analogs of the 
compounds of interest to 3 g blood and 5 mL 
water and sealed each sample in a 10-mL 
headspace vial. We heated (30°C for blood 
and 50°C for water) and agitated (350 rpm 
for blood and 500 rpm for water samples) 
samples using a CTC CombiPal® SPME 
autosampler (LEAP Technology, Carrboro, 
NC) to facilitate extraction of volatiles from 
the sample headspace onto an SPME fiber 
(Carboxen/PDMS, Supelco, Bellefonte, PA). 
After extraction, we inserted the fiber into a 
hot GC (5890 Series II; Agilent Technologies, 
Santa Clara, CA) inlet to desorb volatile com-
pounds that were resolved chromatographi-
cally and then quantified in a high-resolution 
MS (Thermo Finnigan MAT 95; Thermo 
Finnigan, San Jose, CA) for blood and a qua-
drupole MS for water (Trace MS; Thermo 
Finnigan). Final quantification was based on 
daily seven-point calibration curves, and we 
normalized the concentrations according to 
sample weight. The limit of detection (LOD) 
in water was 0.93 μg/L for TCM, 0.21 μg/L 
for BDCM, 0.49 μg/L for DBCM, and 
0.15 μg/L for TBM. The LOD in blood for 
TCM was 2.2 ng/L, 0.24 ng/L for BDCM, 
0.21 ng/L for DBCM, and 0.58 ng/L for 
TBM. Out of 175 water samples, 5% were 
below the LOD for TCM, 2% for BDCM, 
3% for DBCM, and 18% for TBM. Out of 
179 blood samples, 6% were below the LOD 
for TCM, 8% for BDCM, 18% for DBCM, 
and 59% for TBM. Concentrations below the 
LOD were replaced with LOD/√
_
2 (Hornung 
and Reed 1990) for the analyses.
Data collection. The participants self-
 administered a water-use activity diary 24 hr 
before the home visit, and we reminded them 
not to have any contact with water for at least 
4 hr before their home-visit appointment. The 
24-hr diary included information on water 
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consumption practices (e.g., use of filters and 
other point-of-use devices), time, duration 
and location of showering and/or bathing, 
time spent bathing children, time spent wash-
ing dishes (and glove use), use of swimming 
pools, and use of fans and opening of windows 
while showering/bathing one’s self or chil-
dren. Sociodemographic data collected from 
the main epidemiological study (Savitz et al. 
2005) were also available for this population 
[see Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1104347)].
As part of the diary, we asked study 
partici pants how many bottles of water and 
glasses/cups of cold tap water, hot tap water, 
and tap-water–based beverages (including 
juice, coffee, tea, and other beverages made 
from tap water) they consumed each day. We 
also asked that participants define their glass 
or cup sizes according to three options: small 
(0.1–0.3 L), medium (> 0.3–0.6 L), or large 
(> 0.6–1.0 L) for cold tap water beverages and 
small (0.1–0.3 L), medium (> 0.3–0.5 L), or 
large (> 0.5–0.7 L) for hot tap water bever-
ages. We used the midpoint for each size range 
to estimate water consumption in ounces per 
day. We converted bottled water intake (spring 
water, mineral water, distilled water, sparkling 
water, or any water purchased in bottles or 
plastic jugs or obtained from a water cooler) to 
liters based on reported container sizes: small 
(8–12 ounces), medium (14–24 ounces), and 
large (26–34 ounces).
Exposure assessment. To help assess the 
primary determinants of blood THM levels, we 
developed a total daily exposure metric based 
on the main activities that impact ingestion, 
inhalation, and dermal absorption. We used six 
activities to calculate the daily exposure metrics 
for the 24 hr before sampling: a) total tap 
water intake (liters), b) total time showering/
bathing themselves (minutes), c) total time 
showering/bathing children (minutes), d) total 
post shower/bathroom time (minutes), e) total 
time washing dishes (minutes), and f ) total 
time swimming (minutes). We summed intake 
of tap water and tap-water–based beverages 
to estimate ingestion exposure to THMs, 
and we used the reported other activities to 
estimate noningestion exposures. We applied 
a reduction of 70% in THM levels to the 
ingestion estimate for hot beverages, a 50% 
reduction for point-of-use filtration to filtered 
tap water, and a 50% reduction to those 
who reported using gloves while washing 
dishes (Forssén et al. 2007; Krasner and 
Wright 2005). We did not include bottled 
water consumption in the analy sis because it 
typically contains very low levels of THMs 
(Weinberg et al. 2006). Although we did 
not integrate data on the use of fans and the 
opening of windows/doors during showering/
bathing because of the uncertainty associated 
with these specific practices on DBP levels 
(e.g., post shower/bath levels), we performed 
sensitivity analyses (assuming 75% reduction) 
to assess the potential impact of these exposure 
modifying factors on the total estimate of 
ΣTHM exposure.
To integrate equivalent THM dose con-
tributions from different exposure routes, we 
calculated a total exposure metric based on 
the summation of ingestion and noningestion 
activities. To allow for a common metric across 
disparate activities, we used liter- equivalents 
based on human biomonitoring data col-
lected during controlled dermal or inhalation 
studies of TCM (Kerger et al. 2000; Weisel 
and Jo 1996) and previously applied in epi-
demiological studies (Dodds et al. 2004; King 
et al. 2004). The equivalency scores, includ-
ing reductions applied to the afore mentioned 
exposure modifying factors, were based on a 
presumed dose equivalency of 1 L total tap 
water intake, 5-min shower/bath, 15-min 
shower/bath for children, 15-min post shower/
bath time spent in the bathroom, 15 min of 
washing dishes by hand, and a 5-min swim. 
We examined ingestion and noningestion 
THM equivalency score tertiles in relation to 
blood THM concentrations. We restricted 
this analysis (n = 150) to the first reported 
water diary entry for women with both sum-
mer and winter measurements (68% summer, 
32% winter). Given potential toxicokinetic 
differences between specific compounds, we 
performed sensitivity analyses to assess the 
effect of estimated equivalencies (e.g., a 2-min 
shower/bath = 1 L ingested water) on the total 
exposure metric results.
Statistical analysis. We conducted statisti-
cal analyses using SAS statistical software (ver-
sion 9.2; SAS Institute Inc., Cary, NC). We 
calculated descriptive statistics for blood, tap 
water, and sociodemographic characteristics of 
the study participants. We defined ΣTHM as 
the sum of TCM, BDCM, and DBCM, and 
TBM, concentrations in water (micrograms 
per liter) and blood (nanograms per liter). We 
defined brominated high-resolution THMs 
as the sum of BDCM, DBCM, and TBM in 
these two media. We did not weight the sums 
according to bromide content. Descriptive 
tests (skewness, kurtosis), histograms, and 
normal probability plots revealed deviations 
from a normal distribution for DBPs in 
blood and water [see Supplemental Material, 
Figures 2 and 3 (http://dx.doi.org/10.1289/
ehp.1104347)]; therefore, data were log10 
transformed for the regression models and 
analysis of variance (ANOVA). We calculated 
the percentages of the brominated species in 
tap water and blood samples using the geomet-
ric means (GMs) for individual THM species 
and the ΣTHM GM for each site and season. 
We used Spearman rank correlation coeffi-
cients (rS) to quantify the correlation between 
tap water and blood ΣTHM concentrations, 
between sites and seasons, and across individ-
ual THMs. We used paired t-tests to compare 
mean water and blood THM concentrations 
between different seasons of sample collection. 
Because of the small sample size and limited 
number of samples, we restricted the intrain-
dividual variability analysis to the 29 site 1 
participants with repeated measures. We used 
linear regression to estimate the change in 
ΣTHM in blood per unit increase of ΣTHM 
in water. We adjusted the regression models 
for maternal age, ethnicity, education, smok-
ing, marital status, body mass index, house-
hold income, season, study site, and reported 
water-use activities. We selected confounders 
based on percent change (> 10%) in regres-
sion coefficients from the univariate models. 
We performed trend analyses using one-way 
ANOVA to evaluate blood THM concen-
trations across the ingestion, noningestion, 
and total exposure metric tertiles. We defined 
statistical significance as a p-value < 0.05 for 
the regression models, Spearman rank correla-
tions, and ANOVAs.
Results
The study participants were predominantly 
married (78%), Caucasian (69%), and 
between 25 and 34 years of age [67%; see 
Supplemental Material, Table 1 (http://dx.doi.
org/10.1289/ehp.1104347)]. Study partici-
pants commonly consumed tap water (71%), 
and 21% of tap water users reported exclusive 
use of filtered tap water for consumption (data 
not shown). For site 1, the GM tap water 
ΣTHM level was notably higher in summer 
(46.3 μg/L; n = 47) than in winter (25.2 μg/L; 
n = 50; p < 0.01; Table 1). Blood ΣTHM 
concentrations were also higher in summer 
(GM = 26.2 ng/L; n = 47) than in winter 
(GM = 15.9 ng/L; n = 49) for site 1 (p < 0.01). 
Although site 2 had low tap water ΣTHM 
concentrations (GM = 4.8 μg/L; n = 49), the 
GM for blood ΣTHM (12.6 ng/L; n = 49) 
was approximately 60% of the GMs for sites 1 
and 3. Higher tap water ΣTHM levels in 
winter (GM = 28.5 μg/L) were detected in 
site 3 than in the limited number of summer 
samples (GM = 14.6 μg/L). The brominated 
species in tap water were predominant in 
site 2 (75%; summer samples only) and site 3 
(68%; summer and winter samples) but not in 
site 1 (35%; summer and winter samples). The 
proportion of brominated species detected in 
blood was 24% for site 1, 29% for site 2, and 
57% for site 3.
The overall Spearman rank correla-
tion coefficient for ΣTHM concentrations 
in tap water and blood was 0.36 (p < 0.01) 
based on the first measurement for each 
study participant [n = 150; see Supplemental 
Material, Table 2 (http://dx.doi.org/10.1289/
ehp.1104347)]. Despite differences in the rela-
tive proportion of brominated THMs across 
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the different matrices, we found stronger and 
more consistent correlations for BDCM, 
DBCM, TBM, and the sum of the bromi-
nated THMs (rS = 0.53–0.62) than for TCM 
(rS = 0.37). The correlation between water 
and blood ΣTHM concentrations was con-
siderably higher in site 3 (rS = 0.51) than in 
site 1 (rS = 0.12) or site 2 (rS = –0.04). The 29 
participants who had both winter and summer 
samples from site 1 had higher blood ΣTHM 
concentrations in summer (GM = 26.1 ng/L) 
than in winter (GM = 12.3 ng/L; p < 0.01; 
data not shown). The correlation coefficient 
between blood and water ΣTHM was 0.43 
in winter and –0.06 in summer among the 
29 participants with repeated measures. The 
correlation coefficients between the two blood 
and two tap water samples were 0.57 and 
–0.12, respectively.
Blood ΣTHM concentration was lower 
(GM = 15.6 ng/L) in the first noningestion 
tertile than in the second (20.0 ng/L) and 
third tertiles (21.2 ng/L; Table 2; p-value for 
trend = 0.15). Blood ΣTHM concentrations 
also tended to increase across the ingestion ter-
tiles (data not shown). The gradient in blood 
ΣTHM concentrations for the total exposure 
metric derived from liter-equivalent estimates 
was comparable with that for noningestion 
water activities, suggesting little influence 
from ingestion (Table 2). Sensitivity analy-
ses showed minimal changes in blood THM 
concentrations (2–3%) based on 75% reduc-
tion in DBP levels during the post shower/
bathing time due to use of fans or opening of 
windows/doors. Additional sensitivity analy-
ses using the showering/bathing equivalency 
of 10 or 15 min per 1 L of ingested water 
(while keeping other parameters constant) 
showed minimal impacts (4–11%) on mean 
blood THM levels and similar trends (as the 
main results) across the tertiles. Given that 
Leavens et al. (2007) indicate a greater role 
for dermal absorption for the brominated 
compounds than for TCM, we conducted 
sensitivity analyses to examine the contribu-
tion of activities with heavy dermal exposures. 
Therefore, we separately examined the impact 
of changing the swimming and showering/
bathing equivalent to both 1 min and 2 min 
per 1 L ingestion, respectively. Although the 
lowest blood mean levels were consistently 
found among the lowest exposure tertiles, 
monotonic increases were not as evident across 
the tertiles as those found for the main study 
results. Univariate linear regression analysis of 
the first samples collected per subject showed 
that tap water ΣTHM concentration was the 
strongest predictor of blood ΣTHM levels 
among the water-use indicators; for a 1-μg/L 
increase in ΣTHM water levels, blood ΣTHM 
levels increased by 0.21 ng/L (p < 0.01). The 
change in blood levels was 0.19 ng/L per 
1-μg/L increase in ΣTHM tap water concen-
trations (p < 0.05) after adjustment for con-
founding, with ΣTHM water concentration, 
education, and marital status identified as the 
strongest predictors of blood ΣTHM concen-
trations [see Supplemental Material, Table 3 
(http://dx.doi.org/10.1289/ehp.1104347)].
Discussion
Consistent with previously reported studies 
showing THM seasonality in water (Nieminski 
et al. 1993; Parvez et al. 2011; Williams et al. 
1997), we found higher THM concentrations 
in summer tap water samples than in winter 
samples among site 1 participants. Similarly, 
mean baseline blood THM levels among site 1 
participants were higher in summer than in 
winter. Overall, we saw moderate correlations 
between blood and tap water concentrations 
of ΣTHM and all individual THMs; however, 
this was largely due to stronger correlations in 
site 3 (rS = 0.51). Despite differences in the 
relative proportion of brominated compounds 
across the different matrices, water concentra-
tion appeared to be a relatively good marker 
(rS = 0.53) of baseline brominated blood THM 
levels. We also noted fairly consistent blood–
water correlations for BDCM and DBCM 
(rS = 0.26–0.57) across the three sites despite 
some seasonal differences. The TCM blood–
water correlations, however, were more varied 
Table 1. Tap water and blood THM concentrations by season and site for 150 postpartum women.a
Water concentration (μg/L)b Blood concentration (ng/L)c
THM n GM (GSD) Median Range n GM (GSD) Median Range
Site 1
Overall
TCM 97 21.3 (2.4) 31.0 0.18–65.0 96 14.6 (1.8) 14.5 1.5–81.0
BDCM 97 8.5 (2.5) 12.0 BLD–17.0 96 3.0 (1.8) 3.3 0.44–17.0
DBCM 97 3.1 (2.1) 3.0 BLD–7.1 97 1.2 (1.7) 1.2 0.44–8.6
TBM 97 0.19 (1.5) 0.14 BLD–0.80 97 0.77 (1.3) 0.72 0.71–2.4
ΣTHM 97 33.8 (2.2) 47.3 0.38–86.1 96 20.3 (1.7) 21.1 3.1–89.8
Winterd 
TCM 50 16.4 (3.9) 23.0 0.18–65.0 49 11.7 (2.3) 15.7 1.5–81.0
BDCM 50 6.0 (3.6) 8.9 BLD–17.0 49 2.1 (2.2) 2.7 0.44–13.0
DBCM 50 1.9 (2.6) 2.4 BLD–4.0 50 0.74 (1.8) 0.75 0.44–4.3
TBM 50 0.09 (1.3) 0.10 BLD–0.15 50 0.73 (1.1) 0.10 0.71–1.2
ΣTHM 50 25.2 (3.4) 34.6 0.38–86.1 49 15.9 (2.1) 18.0 3.1–89.8
Summer
TCM 47 28.1 (2.4) 34.0 0.1–48.0 47 18.3 (1.8) 18.0 5.3–61.0
BDCM 47 12.2 (2.5) 15.0 0.18–17.0 47 4.6 (1.8) 4.3 0.85–17.0
DBCM 47 5.3 (2.1) 6.4 0.17–7.1 47 2.0 (1.7) 1.9 0.44–8.6
TBM 47 0.42 (1.5) 0.47 BLD–0.80 47 0.82 (1.3) 0.71 0.71–2.4
ΣTHM 47 46.3 (2.2) 55.5 0.77–72.4 47 26.2 (1.7) 24.8 8.1–82.9
Site 2
Summer
TCM 49 0.83 (1.0) 0.90 BLD–4.4 49 6.9 (3.4) 5.4 1.5–130.0
BDCM 49 1.3 (2.0) 1.4 0.19–5.2 49 1.1 (2.1) 1.1 0.44–7.4
DBCM 49 1.6 (1.9) 1.6 0.32–7.0 49 1.1 (2.1) 1.2 0.44–10.0
TBM 49 0.69 (0.8) 0.66 0.15–8.0 49 1.4 (2.0) 1.3 0.71–18.0
ΣTHM 49 4.8 (1.9) 4.6 0.83–19.5 49 12.6 (2.6) 10.7 3.1–132.8
Site 3
Overall
TCM 29 5.2 (10.5) 9.6 BLD–85.0 33 8.6 (2.2) 8.6 1.5–47.0
BDCM 29 6.3 (12.0) 18.0 BLD–66.0 33 5.5 (2.1) 5.5 1.3–30.0
DBCM 29 8.1 (7.3) 19.0 BLD–41.0 33 5.6 (2.0) 6.3 1.5–27.0
TBM 29 2.5 (3.9) 4.1 BLD–9.5 33 2.1 (1.8) 1.8 0.71–7.8
ΣTHM 29 24.8 (7.6) 52.7 BLD–197.2 33 23.1 (1.9) 22.8 6.1–107.8
Winter
TCM 23 5.8 (10.3) 12.0 BLD–85.0 27 8.7 (2.4) 8.6 1.5–47.0
BDCM 23 7.3 (10.7) 18.0 BLD–66.0 27 5.6 (2.2) 5.5 1.3–30.0
DBCM 23 9.3 (6.0) 18.0 BLD–41.0 27 5.7 (2.1) 6.4 1.5–27.0
TBM 23 2.7 (3.2) 4.1 BLD–7.2 27 2.0 (1.8) 1.8 BLD–7.8
ΣTHM 23 28.5 (6.5) 52.5 BLD–197.2 27 23.5 (2.0) 22.8 6.1–107.8
Summer
TCM 6 3.2 (12.9) 8.7 BLD–45.0 6 8.1 (1.6) 8.7 4.6–14.0
BDCM 6 3.4 (21.1) 19.5 BLD–32.0 6 4.7 (1.9) 5.6 2.0–9.6
DBCM 6 4.8 (16.1) 26.0 BLD–34.0 6 5.2 (1.9) 6.3 1.6–9.1
TBM 6 1.9 (7.9) 6.0 BLD–9.5 6 2.4 (1.8) 2.6 1.2–4.8
ΣTHM 6 14.6 (14.3) 65.0 BLD–104.8 6 21.8 (1.5) 25.7 12.2–30.6
Abbreviations: BLD, below the LOD (replaced with LOD/√
_
2 for the analysis); GSD, geometric standard deviation.
aSeventy-four women provided samples in summer, 48 in winter, and 29 in summer and winter. bNine water samples 
were not examined because of unacceptable headspace volume and/or freezing of vials. cFour blood samples were 
excluded because of laboratory data quality concerns. dOne blood sample failed laboratory quality controls for TCM, 
BDCM, and ΣTHM for site 1 in winter.
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(–0.05 to 0.57) across sites and seasons and 
may reflect unmeasured exposures to potential 
sources not related to water (e.g., occupational 
exposures, pharmaceuticals, consumer products, 
bleach-based cleaning agents, ambient air).
We saw comparable mean baseline blood 
ΣTHM levels in sites 1 and 3 (20–23 ng/L). 
Despite much lower THM concentrations in 
tap water, the mean blood ΣTHM concen-
tration among site 2 participants was roughly 
60% of the means for sites 1 and 3. This 
was primarily due to the disproportionately 
high baseline blood TCM concentrations for 
site 2, as shown in a previous study of baseline 
blood THM levels among women using heav-
ily brominated waters (Miles et al. 2002). In 
addition to potential exposure to TCM from 
non water sources, the route of exposure can 
also be a critical determinant of internal THM 
levels. Miles et al. (2002) reported that blood 
and water concentrations were more closely 
correlated after high THM dose events such 
as showering. Rapid hepatic metabolism or 
elimination occurs for ingested THMs, but 
THM exposures from inhalation and dermal 
absorption are distributed directly to the blood 
(Blount et al. 2011; Leavens et al. 2007). Some 
of the differences detected for baseline blood 
THM levels may also reflect genetic variabil-
ity or induction of metabolizing enzymes by 
alcohol, medications, or drugs, as some stud-
ies have noted a 50-fold variability in cyto-
chrome P450 (CYP) 2E1 enzyme activity in 
humans (Stephens et al. 1994). The predomi-
nant route of metabolism for THMs is oxi-
dation via CYP2E1 (Guengerich et al. 1991; 
Lilly et al. 1997), whereas secondary metabolic 
pathways include reductive dehalogenation 
via CYP2B1/2 and CYP2E1 (and possibly 
CYP1A2) (Allis and Zhao 2002; Tomasi et al. 
1985) and glutathione conjugation via glutathi-
one S-transferase theta (GSTT11) (DeMarini 
et al. 1997; Pegram et al. 1997). Genetic poly-
morphisms can vary widely by race and ethnic-
ity; however, the preponderance of Caucasians 
in our sample population (69%) limited our 
ability to examine this as a potential contrib-
uting factor. Lack of data on medication use, 
occupational exposures, and use of consumer 
products precluded examination of the influ-
ence of these factors on blood THM levels.
In contrast to the 59% of brominated 
THMs detected in tap water across all three 
sites, we found lower proportions in blood 
(37%). Lower relative proportions of baseline 
brominated blood THMs have been observed 
in previous studies (Backer et al. 2000, 2008; 
Miles et al. 2002). These findings are con-
sistent with known toxicokinetic differences 
between the individual THMs, as brominated 
THMs are more readily metabolized and are 
more lipophilic than TCM (Lilly et al. 1997). 
Partitioning of THMs from fat to blood and 
their subsequent metabolism were likely the 
predominant factors affecting baseline blood 
concentrations. Thus, slower release of bro-
minated THMs from fat and more rapid pri-
mary metabolism would lead to lower baseline 
blood levels of brominated THMs compared 
with TCM. The molar rate of metabolism of 
the brominated THMs is greater than that of 
TCM (Lilly et al. 1997), and therefore, the 
brominated THM mass would decrease at a 
more pronounced rate compared with TCM. 
This shift toward less brominated species in 
blood may also be related to the exposure levels 
that women are experiencing from ambient air 
because more volatile species, such as TCM, 
are available for inhalation than are the more 
reactive brominated species. Dose levels from 
ambient air and drinking water exposures 
can also affect the metabolic pathway that is 
engaged. For example, brominated THMs 
are much more likely than TCM to proceed 
through secondary metabolic pathways, with 
GST-mediated conjugation of TCM to gluta-
thione occurring only at extremely high TCM 
concentrations or doses (DeMarini et al. 1997; 
Pegram et al. 1997). As such, this may also 
help explain the higher relative TCM blood 
levels among site 2 participants with low tap 
water TCM concentrations. Given increasing 
epidemiological and toxicological evidence of 
health effects from DBPs being modulated by 
genetic polymorphisms (Cantor et al. 2010; 
DeAngelo et al. 1999; DeMarini et al. 1997; 
Kogevinas et al. 2010; Pegram et al. 1997), 
future studies should examine the variability 
in THM metabolism and clearance among 
susceptible populations.
The individual-level information collected 
on blood THM and residential tap water con-
centrations, water-use activities, and socio-
demographic data among post partum women 
was a strength of the study, but the small 
sample size limited our ability to fully eluci-
date independent contributors of blood THM 
concentrations. We had minimal repeated 
measures among participants to examine 
intraindividual differences, and data collected 
from only two seasons did not allow a more 
detailed assessment of temporal changes in 
baseline blood THM levels. We also had lim-
ited ability to examine the impact of episodic 
high THM dose events because few partici-
pants reported bathing (9%) and swimming 
(2%) in the 24-hr water-use diary. The women 
providing the convenience samples in our study 
were motivated and highly educated and repre-
sented a low-risk population. Although this 
non random sample may not be representative 
of the general population, there is little reason 
to suspect that the relationships found here 
would not be applicable to other groups.
Despite these limitations, the detailed self-
reported data allowed us to develop aggregate 
Table 2. The influence of noningestion exposure and total exposure metrics on blood ΣTHM concentra-
tions for 150 postpartum women.
Noningestion exposures (ng/L)a Total exposure (ng/L)b
Exposure metric GM (GSD) Median Range GM (GSD) Median Range
TCM
Tertile 1 9.0 (4.3) 8.6 1.5–61.0 10.1 (2.3) 9.8 1.5–61.0
Tertile 2 10.7 (3.1) 12.0 1.5–130.0 9.6 (2.1) 12.0 1.5–130.0
Tertile 3 12.6 (5.3) 13.0 1.5–81.0 12.4 (1.4) 13.0 1.5–81.0
BDCM
Tertile 1 2.0 (1.2) 2.2 BLD–15.0 2.3 (2.1) 2.5 BLD–15.8
Tertile 2 3.3 (1.5) 3.6 BLD–15.8 3.0 (2.3) 3.8 BLD–17.0
Tertile 3 2.7 (1.4) 2.8 BLD–30.0 2.6 (1.4) 2.7 BLD–30.0
DBCM
Tertile 1 1.4 (1.7) 1.3 BLD–9.7 1.5 (0.9) 1.4 BLD–14.0
Tertile 2 2.1 (2.2) 2.1 BLD–14.0 2.0 (0.7) 2.1 BLD–9.7
Tertile 3 1.9 (1.4) 1.7 BLD–27.4 1.8 (1.3) 1.7 BLD–27.0
TBM
Tertile 1 1.1 (0.9) 0.7 BLD–16.0 1.1 (1.2) 0.7 BLD–16.0
Tertile 2 1.2 (0.8) 1.1 BLD–18.0 1.2 (1.9) 1.0 BLD–18.0
Tertile 3 1.2 (1.4) 0.9 BLD–7.8 1.2 (0.8) 1.1 BLD–7.8
Brominated THMs
Tertile 1 5.2 (2.1) 4.7 1.6–22.3 5.5 (2.4) 5.0 1.6–30.4
Tertile 2 7.3 (1.2) 7.4 1.6–30.4 6.9 (3.9) 7.4 1.9–27.2
Tertile 3 6.3 (1.3) 5.7 1.6–60.8 6.1 (3.2) 6.0 1.6–60.8
ΣTHM
Tertile 1 15.6 (8.6) 17.7 3.1–82.9 17.0 (3.8) 17.7 3.6–82.9
Tertile 2 20.0 (7.5) 21.5 4.0–132.8 18.6 (4.1) 22.5 3.1–132.8
Tertile 3 21.2 (10.8) 22.2 3.1–107.8 20.7 (3.4) 21.2 3.1–107.8
aNoningestion exposures: showering/bathing, bathing children, post shower/bathroom time, washing dishes by hand, 
and swimming. Exposure categories are based on the tertiles of the sum (minutes) of the noningestion exposures with 
the following cut points: tertile 1, ≤ 33 min; tertile 2, > 33–59 min; tertile 3, > 59 min. bTotal exposure includes ingestion 
and noningestion exposures. Equivalencies: ingestion exposure = 1 L total tap water, 5 min. Noningestion exposures: 
shower/bathing, 5 min; bathing children, 15 min; postshower/bathroom time, 15 min; washing dishes, 15 min; swimming, 
5 min (70% reduction was applied to hot beverages and 50% when point-in-use filtration or wearing gloves while wash-
ing the dishes was reported). Exposure categories were based on the tertiles of equivalency scores with the following 
cut points: tertile 1, score ≤ 4.58; tertile 2, score 4.59–6.87; tertile 3, score > 6.87.
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exposure metrics that addressed the multi route 
exposure of volatile DBPs such as the THMs. 
We detected increasing blood THM concen-
trations across exposure metrics based on the 
noningestion metric alone or a total exposure 
metric based on ingestion and noningestion 
data. For example, the noningestion metric 
showed that women who spent more time 
engaging in water-use activities (i.e., show-
ering and bathing oneself, bathing children, 
washing dishes) had higher blood ΣTHM 
levels. The liter-equivalents used here and in 
previous epidemiological studies (Dodds et al. 
2004; King et al. 2004) were based on experi-
mental studies of TCM (Kerger et al. 2000; 
Weisel and Jo 1996), but more recent find-
ings by Haddad et al. (2006) and Valcke and 
Krishnan (2010) provide additional support 
for the equivalencies used to examine the rela-
tionship between showering and ingestion. 
The results of the sensitivity analyses indicate 
that the mean blood THM levels for the total 
exposure metric tertiles were not very sensitive 
to changes in equivalencies for activities largely 
driven by dermal absorption or inhalation. 
Overall, the total exposure metric, based on 
liter-equivalents, was not a strong predictor of 
baseline blood THM levels after adjusting for 
tap water ΣTHM concentrations and other 
sociodemographic variables.
In summary, we detected temporal and spa-
tial variability in baseline blood THM concen-
trations in our study population. Water THM 
levels tended to vary more than blood THM 
levels in our population, and blood–water cor-
relations for ΣTHM and individual THMs dif-
fered across sites and seasons. The blood–water 
correlations for the brominated THMs were 
much stronger than for TCM and more consis-
tent across study locations. As noted previously, 
the TCM results could be more affected by 
metabolic differences, other non water sources, 
or other factors that may vary across site or 
seasons. Our study results may prove useful 
in future epidemiological studies that exam-
ine THM exposure surrogates or that quantify 
the degree of bias from exposure measurement 
error, because the brominated THMs are more 
potent toxicants and carcinogens than TCM 
in experimental studies (Plewa et al. 2008) and 
thus are of greater concern for potential adverse 
health effects in humans. The results from our 
regression analysis also provide some support 
that tap water concentrations are predictive of 
baseline blood biomarker levels. THM water 
concentrations were also found to be an impor-
tant predictor of post shower blood THM lev-
els in a previous study (Backer et al. 2008). 
Our multi variate regression analyses indicated 
that the liter-equivalency–based metrics were 
not predictive of baseline blood THM con-
centrations; however, they still may hold some 
value at predicting peak blood THM levels in 
 epidemio logical studies.
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